Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 13:37 (588 d 17:41 ago) – Posting: # 19925
Views: 915

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,076 posts in 4,394 threads, 1,468 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Saturday 08:19 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5